Hepatic lipase mutation may reduce vascular disease prevalence in hemodialysis patients with high CETP levels.
暂无分享,去创建一个
F. Gejyo | H. Kimura | H. Yoshida | Ryoichi Miyazaki | S. Suzuki | S. Masunaga | T. Imura | H. Yoshida
暂无分享,去创建一个
F. Gejyo | H. Kimura | H. Yoshida | Ryoichi Miyazaki | S. Suzuki | S. Masunaga | T. Imura | H. Yoshida